Literature DB >> 3280569

Expression of soluble and fully functional ricin A chain in Escherichia coli is temperature-sensitive.

M Piatak1, J A Lane, W Laird, M J Bjorn, A Wang, M Williams.   

Abstract

Linkage of ricin A chain (RA) to a cell surface binding antibody or other ligand can result in a potent cytotoxic agent. We expressed the primary sequence for RA in Escherichia coli to facilitate production and to obtain protein free of naturally occurring contaminants, i.e. ricin B chain. Differences in the level of expression and in the characteristics of the expressed protein were noted when several different host/vector systems were tested. Recombinant RA (rRA) was expressed directly under control of the phage lambda major leftward promoter (PL) and the E. coli trp promoter. It was also expressed fused to E. coli alkaline phosphatase sequences, both in the same reading frame for secretion and out-of-reading frame for expression in a cistron-like arrangement. Expression in the PL promoter system, which is temperature-regulated, was achieved at 37 degrees C as well as at 42 degrees C. The protein expressed at these different temperatures had grossly different properties. Whereas rRA expressed at 37 degrees C was soluble and fully active, that produced at 42 degrees C was aggregated, insoluble, and reduced in activity. Soluble rRA could be converted to the insoluble form by incubation at 42 degrees C in vivo, but not in vitro. Hence, this difference in properties does not simply reflect an inherent thermal instability of the protein. Conditions present in vivo, including the possible association with other proteins, are apparently required for this effect on rRA.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3280569

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Protein compositional analysis of inclusion bodies produced in recombinant Escherichia coli.

Authors:  U Rinas; J E Bailey
Journal:  Appl Microbiol Biotechnol       Date:  1992-08       Impact factor: 4.813

2.  Role of glutamic acid 177 of the ricin toxin A chain in enzymatic inactivation of ribosomes.

Authors:  D Schlossman; D Withers; P Welsh; A Alexander; J Robertus; A Frankel
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

3.  Purification and characterization of recombinant tissue kallikrein from Escherichia coli and yeast.

Authors:  J Wang; J Chao; L Chao
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

4.  Determination by systematic deletion of the amino acids essential for catalysis by ricin A chain.

Authors:  K N Morris; I G Wool
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

5.  Purification and characterization of recombinant Streptomyces clavuligerus isopenicillin N synthase produced in Escherichia coli.

Authors:  M Durairaj; S E Jensen
Journal:  J Ind Microbiol       Date:  1996-03

6.  Purification, characterization and molecular cloning of trichoanguin, a novel type I ribosome-inactivating protein from the seeds of Trichosanthes anguina.

Authors:  L P Chow; M H Chou; C Y Ho; C C Chuang; F M Pan; S H Wu; J Y Lin
Journal:  Biochem J       Date:  1999-02-15       Impact factor: 3.857

7.  Effects of temperature and novobiocin on the expression of calf prochymosin gene and on plasmid copy number in recombinant Escherichia coli.

Authors:  F Kaprálek; P J Tichý; M Fábry; J Sedlácek
Journal:  Folia Microbiol (Praha)       Date:  1998       Impact factor: 2.099

8.  Selection and characterization of ricin toxin A-chain mutations in Saccharomyces cerevisiae.

Authors:  A Frankel; D Schlossman; P Welsh; A Hertler; D Withers; S Johnston
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

9.  Diphtheria toxin mutant selectively kills cerebellar Purkinje neurons.

Authors:  C J Riedel; K M Muraszko; R J Youle
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

Review 10.  Progress and challenges associated with the development of ricin toxin subunit vaccines.

Authors:  David J Vance; Nicholas J Mantis
Journal:  Expert Rev Vaccines       Date:  2016-04-06       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.